Skip to content
ClinCalc Pro
Menu
Inhaled Corticosteroid (ICS)

Budesonide (Inhaled)

Brand names: Pulmicort, Symbicort component

This is inhaled budesonide, a corticosteroid used as regular preventer therapy for asthma and as maintenance anti-inflammatory treatment in COPD, taken to reduce airway inflammation and exacerbations.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

The inhaled glucocorticoid binds airway glucocorticoid receptors to suppress local inflammation and reduce bronchial hyper-responsiveness.

Prescribing in practice

  • Most important: it is a preventer that must be used regularly and does not relieve an acute attack, so a short-acting reliever must remain available.
  • Confirm correct technique for the specific device and consider a spacer with a metered-dose inhaler to improve deposition.
  • Use the lowest effective dose to maintain control and review periodically.

Monitoring

Monitor asthma or COPD control, inhaler technique, oral candidiasis, and childhood growth on prolonged use.

Counselling the patient

  • Rinse the mouth after inhaling to reduce thrush and hoarseness.
  • Continue daily even when symptom-free, as the protective effect is cumulative.

Evidence & guidelines

Inhaled budesonide is well established as preventer therapy in NICE and GINA asthma guidance and within COPD combination regimens.

Reference: GINA 2024; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.